UN Researcher Envisions Framework For IP, Innovation and Development 06/09/2006 by William New, Intellectual Property Watch Leave a Comment By William New The impact of intellectual property policy on innovation and development may have been overstated, and a framework is needed for analysing the linkage between these concepts in developing countries, according to a United Nations researcher. While intellectual property policy is a key element of innovation policy, “the focus has been selective, and […]
India: Influential Voices Back “IP-unencumbered” Software; Copyright Debate Heats Up 05/09/2006 by Frederick Noronha for Intellectual Property Watch Leave a Comment By Frederick Noronha for Intellectual Property Watch NEW DELHI – For a judge, Yatindra Singh of India’s Allahabad high court is surprisingly outspoken. For a member of the bench, he is also amazingly tech-savvy. And as he talks technology, or explains to an Indian businessman how free software, unencumbered by intellectual property, can get support […]
India At The Forefront Of Knowledge Commons Debate 03/09/2006 by Frederick Noronha for Intellectual Property Watch 3 Comments By Frederick Noronha for Intellectual Property Watch NEW DELHI – What do seeds have in common with software? Or age-old medicines with copyright lawyers? And, what’s the link between ayurvedic medicines and techies talking free software in Bangalore? Such issues are getting closely enmeshed in a deepening debate on how knowledge is shared or controlled […]
Pfizer Fights IP Flexibilities In The Philippines 30/04/2006 by Tove Iren S. Gerhardsen for Intellectual Property Watch 5 Comments The world’s largest pharmaceutical company, Pfizer, is suing the Philippine government for having imported and registered – but not marketed – a product that is still under patent. At the same time, industry is said to be lobbying against a bill under consideration in the Philippines that would introduce more flexibilities into the country’s intellectual […]
Patent On AIDS Drug Will Not Limit Access In India, Industry Argues 30/03/2006 by Tove Iren S. Gerhardsen for Intellectual Property Watch 1 Comment It is “misleading” and “counter-productive” to assert that a pharmaceutical company’s filing for a patent on a HIV/AIDS drug in India will limit access to the drug in the future, GlaxoSmithKline said in response to an objection submitted today in India. The comment is a response to the submission of a “pre-grant opposition” to the […]
Protest Submitted To First Patent Filing Of HIV/AIDS Drug In India 30/03/2006 by Tove Iren S. Gerhardsen for Intellectual Property Watch 1 Comment Two Indian HIV/AIDS networks and an international group of lawyers today submitted a protest to the first application for a patent for an HIV/AIDS drug filed in India. The opportunity to stage a “pre-grant opposition” is the “beauty of the Indian patent system,” said Ellen ‘t Hoen of Médecins Sans Frontières (MSF) in an interview. […]
Indian Industry Pushing for Compulsory Licenses for Tamiflu 25/10/2005 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment While Swiss-based Roche, the rights holder to the most-favoured medicine for avian influenza, is pursuing sub-licenses, India is moving ahead with exploring the option of compulsory licensing. If this goes through, India would be able to export Tamiflu to developing countries and certain developed countries. The Indian Cabinet is considering issuing compulsory licenses to local […]
India’s TRIPS Compliance Effort Could Be Test Case 24/03/2005 by William New, Intellectual Property Watch 1 Comment In what could be seen as a “test case” for the balance between intellectual property protection and the promotion of public health, the Indian government today appeared to meet a World Trade Organisation obligation by passing a law on the protection of pharmaceutical and agricultural chemical patents. But the Indian Parliament made a number of […]
U.S. Official Cites Possible Chinese TRIPs Violations 18/02/2005 by William New, Intellectual Property Watch 1 Comment [Editor’s Note: This story was modified at 6.30pm on Friday 18/2/2005] Washington, D.C.—A key U.S. official based in Beijing on Thursday cited several ways that China’s interpretation of its criminal code may violate the World Trade Organisation Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs). But Mark Cohen, the intellectual property attaché at the […]